Bibliography
- Gupta AK, Simpson FC. New therapeutic options for onychomycosis. Expert Opin Pharmacother 2012;13:1131-42
- Shivakumar HN, Juluri A, Desai BG, Murthy SN. Ungual and transungual drug delivery. Drug Dev Ind Pharm 2012;38:901-11
- Zaias N. Onychomycosis. Arch Dermatol 1972;105:263-74
- Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol 2011;65:1219-27
- Hafeez F, Hui X, Chiang A, et al. Transungual delivery of ketoconazole using novel lacquer formulation. Int J Pharm 2013;456:357-61
- Tanriverdi ST, Ozer O. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis. Eur J Pharm Sci 2013;48:628-36
- Monti D, Saccomani L, Chetoni P, et al. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. Drug Dev Ind Pharm 2005;31:11-17
- Monti D, Saccomani L, Chetoni P, et al. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity. Br J Dermatol 2010;162:311-17
- Baran R, Tosti A, Hartmane I, et al. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol 2009;23:773-81
- Gupta AK, Simpson FC. Efinaconazole: a new topical treatment for onychomycosis. Skin Therapy Lett 2014;19:1-4
- Elewski BE, Rich P, Pollak R, et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol 2013;68:600-8
- Jones T, Tavakkol A. Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis. Antimicrob Agents Chemother 2013;57:2684-9
- ClinicalTrials.gov. Safety and Efficacy of Luliconazole Solution, 10% in Subjects with Mild to Moderate Onychomycosis. In. 12 December 2011 ed 2011
- Del Rosso JQ, Plattner JJ. From the test tube to the treatment room: fundamentals of boron-containing compounds and their relevance to dermatology. J Clin Aesthet Dermatol 2014;7:13-21
- ClinicalTrials.gov. Cumulative Irritation Test. In. 11 December 2011 ed 2011
- Sigurgeirsson B, Ghannoum M. Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis. Expert Opin Investig Drugs 2012;21:1549-62
- Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician 2013;88:762-70
- Del Rosso JQ. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol 2014;7:10-18